sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks Pramiracetam

Pramiracetam

CAS No.:
68497-62-1
Catalog Number:
AG0039FL
Molecular Formula:
C14H27N3O2
Molecular Weight:
269.3831
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
95%
In Stock USA
United States
$240
- +
5g
95%
In Stock USA
United States
$669
- +
Product Description
Catalog Number:
AG0039FL
Chemical Name:
Pramiracetam
CAS Number:
68497-62-1
Molecular Formula:
C14H27N3O2
Molecular Weight:
269.3831
MDL Number:
MFCD27977197
IUPAC Name:
N-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
InChI:
InChI=1S/C14H27N3O2/c1-11(2)17(12(3)4)9-7-15-13(18)10-16-8-5-6-14(16)19/h11-12H,5-10H2,1-4H3,(H,15,18)
InChI Key:
ZULJGOSFKWFVRX-UHFFFAOYSA-N
SMILES:
O=C(CN1CCCC1=O)NCCN(C(C)C)C(C)C
UNII:
4449F8I3LE
Properties
Complexity:
308  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
269.21g/mol
Formal Charge:
0
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
269.389g/mol
Monoisotopic Mass:
269.21g/mol
Rotatable Bond Count:
7  
Topological Polar Surface Area:
52.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.8  
Literature
Title Journal
[Platelet hyperreactivity and antiaggregatory properties of nootropic drugs under conditions of alloxan-induced diabetes in rats]. Eksperimental'naia i klinicheskaia farmakologiia 20120101
Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Drugs 20100212
Diisoprop-yl{2-[2-(2-oxopyrrolidin-1-yl)acetamido]eth-yl}ammonium hydrogen sulfate. Acta crystallographica. Section E, Structure reports online 20080601
[Application of nootropic agents in complex treatment of patients with concussion of the brain]. Likars'ka sprava 20070101
Brahmi rasayana improves learning and memory in mice. Evidence-based complementary and alternative medicine : eCAM 20060301
[Experience in the application of pramistar, a new nootropic preparation, in the treatment of memory disorders in patients with cerebrovascular pathology]. Likars'ka sprava 20031201
Therapeutic approaches to age-associated neurocognitive disorders. Dialogues in clinical neuroscience 20010901
Properties